TCM quarterly results and financials

TCM (BSE 524156)₹44.99−2.20%(9 Nov 2026 close)Commodity Chemicals

Key facts

In the Jun 2026 quarter (consolidated), TCM reported sales of ₹4.86 Cr, up 51.9% from Jun 2025, and net profit of −₹1.59 Cr. For the year to Mar 2026, sales were ₹19.66 Cr and net profit −₹5.98 Cr.

Sales (Jun 2026): ₹4.86 Cr
Net profit (Jun 2026): −₹1.59 Cr
Sales (FY Mar 2026): ₹19.66 Cr
Net profit (FY Mar 2026): −₹5.98 Cr
EPS (Jun 2026): ₹−2.15
Borrowings (Mar 2026): ₹22.19 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

TCM quarterly results

₹ crore unless stated; each column is a quarter.

TCM Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	5.02	11.25	8.56	5.26	6.87	6.15	7.62	3.20	5.90	5.67	4.90	4.86
Expenses	6.67	10.49	9.22	6.30	7.47	6.75	7.56	5.15	6.73	6.22	6.06	5.85
Operating Profit	−1.65	0.77	−0.66	−1.05	−0.58	−0.58	0.05	−1.97	−0.82	−0.56	−1.17	−0.99
OPM %	−32.6%	6.9%	−7.6%	−19.8%	−8.6%	−9.6%	0.8%	−61.1%	−14.1%	−9.7%	−23.6%	−20.2%
Other Income	0.04	0.05	0.35	0.05	0.04	0.05	4.35	0.07	0.61	0.08	0.22	0.07
Interest	0.05	0.05	0.01	0.00	0.00	0.27	0.30	0.38	0.49	0.53	0.49	0.51
Depreciation	0.06	0.06	0.09	0.07	0.07	0.08	0.09	0.09	0.10	0.16	0.17	0.15
Profit before tax	−1.75	0.68	−0.44	−1.07	−0.65	−0.89	4.00	−2.40	−0.85	−1.16	−1.62	−1.61
Tax %	0.0%	0.0%	9.3%	0.0%	0.0%	0.0%	−0.8%	−1.7%	0.0%	0.0%	0.0%	0.0%
Net Profit	−1.73	0.68	−0.45	−1.08	−0.62	−0.89	4.02	−2.34	−0.82	−1.17	−1.62	−1.59
EPS (Rs)	−2.22	0.99	−0.49	−1.32	−0.77	−1.16	5.40	−3.01	−1.05	−1.53	−2.22	−2.15

TCM profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

TCM Profit and loss
	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	0.39	0.91	4.21	3.54	7.32	32.12	25.90	19.66	21.33
Expenses	1.25	1.74	5.10	7.54	10.98	34.38	27.87	24.17	24.86
Operating Profit	−0.85	−0.84	−0.89	−4.00	−3.65	−2.23	−1.95	−4.52	−3.54
OPM %	−215.1%	−90.3%	−20.8%	−113.0%	−49.8%	−6.9%	−7.6%	−22.9%	−16.6%
Other Income	0.03	1.16	1.24	−1.70	0.01	0.44	4.30	0.97	0.98
Interest	0.11	0.00	0.00	0.00	0.27	0.15	0.60	1.91	2.02
Depreciation	0.00	0.00	0.02	0.16	0.36	0.29	0.34	0.55	0.58
Profit before tax	−0.93	0.31	0.32	−5.89	−4.28	−2.26	1.38	−6.02	−5.24
Tax %	0.0%	0.0%	61.3%	0.0%	−0.7%	1.8%	−2.2%	−0.7%	—
Exceptional items	0.00	0.00	0.00	−1.99	0.00	0.00	0.00	0.00	—
Net Profit	−0.94	0.29	0.11	−5.87	−4.26	−2.28	1.39	−5.98	−5.20
EPS (Rs)	−1.26	0.41	0.15	−6.86	−5.34	−2.62	2.16	−7.78	−6.95
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

TCM balance sheet

₹ crore, at each year end.

TCM Balance sheet
	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	3.41	3.41	3.41	3.41	7.49	7.47	7.47	7.47
Reserves	28.90	28.95	29.08	21.85	23.18	21.24	22.96	17.17
Borrowings	5.39	5.65	5.84	6.54	1.45	0.28	11.23	22.19
Other Liabilities	31.39	27.34	29.29	29.56	36.60	54.63	34.62	35.56
Total Liabilities	69.09	65.35	67.62	61.36	68.72	83.62	76.28	82.39
Fixed Assets	57.96	57.92	58.71	55.20	35.67	17.26	14.08	16.38
CWIP	0.00	0.00	0.05	0.03	0.11	0.09	0.11	0.26
Investments	0.45	0.20	0.19	0.00	0.00	0.00	0.31	0.31
Other Assets	10.68	7.23	8.67	6.13	32.94	66.27	61.78	65.44
Inventories	1.69	1.50	2.40	1.36	3.78	30.54	28.37	26.68
Trade receivables	1.50	1.77	2.51	1.89	4.67	8.47	6.74	6.22
Cash & equivalents	3.73	0.01	0.08	0.29	0.20	0.55	0.42	0.79
Total Assets	69.09	65.35	67.62	61.36	68.72	83.62	76.28	82.39

TCM cash flow

₹ crore, for each year.

TCM Cash flow
	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	−1.62	−0.56	0.38	−4.20	−10.84	1.94	−10.04	−5.20
Cash from investing activity	0.02	0.00	−0.52	4.23	5.85	−0.65	−0.19	−3.61
Cash from financing activity	5.33	−3.15	0.19	0.20	4.88	−1.31	10.38	9.03
Net cash flow	3.70	−3.71	0.07	0.21	−0.16	0.00	0.12	0.22
Capex	0.00	0.00	0.90	0.14	2.18	0.58	0.51	0.77
Free cash flow	−1.61	−0.56	−0.51	−0.51	−13.04	1.35	−10.58	−5.99
CFO / OP %	190.0%	68.9%	−44.0%	104.9%	296.0%	−100.1%	522.0%	113.0%

TCM ratios

Working-capital days and returns, by year.

TCM Ratios
	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	1,379	707	218	196	234	97	96	116
Inventory days	1,476	847	467	191	269	851	570	682
Days payable	2,582	1,916	745	78	92	80	51	45
Cash conversion cycle	274	−361	−58	310	411	870	616	755
Working capital days	−10,986	−3,261	−818	−1,356	−488	98	−74	224
ROCE %	—	0.8%	−0.2%	−10.6%	−12.9%	−7.0%	6.3%	−9.5%

TCM: frequently asked questions

What are the latest quarterly results of TCM?

For the Jun 2026 quarter, TCM reported sales of ₹4.86 Cr, up 51.9% year on year and net profit of −₹1.59 Cr. The operating margin was −20.2%.

What is the annual revenue of TCM?

TCM's sales for the year to Mar 2026 were ₹19.66 Cr; over the last twelve months they were ₹21.33 Cr.

What is the net profit of TCM?

Net profit for the year to Mar 2026 was −₹5.98 Cr, and −₹5.20 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−6.95.

How much debt does TCM have?

TCM reported borrowings of ₹22.19 Cr at Mar 2026, against cash and equivalents of ₹0.79 Cr.

What is the free cash flow of TCM?

Cash from operations was −₹5.20 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹5.99 Cr.

Loading…